Here are four things to know.
1. Theresa Mullin, PhD, former director of the office of strategic programs at the Center for Drug Evaluation and Research, will now serve as the associate director for strategic initiatives.
2. Ms. Mullin joined the CDER in 2007. In her new role, she will ensure the strategic programs have proper leadership for continued success.
3. Keagan Lenihan, former political appointee at HHS and director of government relations at drugmaker McKesson, will assume the role of associate commissioner for strategic initiatives. In her new role, Ms. Lenihan will work on big-picture projects, combining her expertise in politics and pharmaceutical manufacturing.
4. Ms. Lenihan was personally recruited for the role by FDA Commissioner Scott Gottlieb, MD, according to Politico.
More articles on executive moves:
Huntsville Memorial Hospital CEO suddenly resigns: 4 things to know
CEO, chief nursing officer out at Emanuel Medical Center: 8 notes
MedStar Health appoints first-ever chief scientific officer
